Halozyme Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
Good evening, everyone, and thank you for joining us. So today, we're delighted to be hosting Helen from Halozyme.
Questions & Answers
And just wanted to go ahead and kick off with the first question. For an opportunity for Helen to speak at a high level about the business operations and driving growth through pipeline candidates that you've laid out and through portfolio diversification, through business development, I would love if you could talk about the business and give us a broad overview.
Yes. Thanks for this opportunity. So Halozyme is a profitable biotech company. We are focused on bringing forward disruptive solutions that can improve the treatment experience and potentially also improve outcomes. We do this through 2 drug delivery technologies that's focused on subcutaneous delivery, and we also have a specialty pharmaceutical business as well.
When we think about our drug delivery
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
